Page last updated: 2024-08-25

rosiglitazone and Parasitemia

rosiglitazone has been researched along with Parasitemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boggild, AK; Kain, KC; Katz, K; Krudsood, S; Liles, WC; Looareesuwan, S; Patel, SN; Serghides, L; Tangpukdee, N; Wilairatana, P	1

Trials

1 trial(s) available for rosiglitazone and Parasitemia

Article	Year
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Sep-15, Volume: 49, Issue:6 Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult	2009

Article

Year

Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, Sep-15, Volume: 49, Issue:6

Topics: Adjuvants, Immunologic; Adolescent; Adult; Animals; Antimalarials; Atovaquone; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Immunity, Innate; Inflammation; Inflammation Mediators; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Plasmodium falciparum; PPAR gamma; Proguanil; Rosiglitazone; Thailand; Thiazolidinediones; Time Factors; Treatment Outcome; Young Adult

2009